This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Oncology  • Breast Cancer  • Radiation Therapy  • Radiologic Imaging  • Women's Health  • Women's Health, Other  • Randomized Controlled Trial  • Magnetic Resonance Imaging  • Mammography  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

Tracy Hampton, PhD

JAMA. 2007;298:389-390.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Chicago—Findings from several breast cancer clinical trials involving diagnostic imaging, radiation, and chemotherapy could lead to changes in screening and treatment options for women, according to researchers presenting data at the 43rd annual meeting of the American Society of Clinical Oncology (ASCO), held here in June.

"We’ve really made tremendous progress in detecting and treating [breast] cancer," said Julie Gralow, MD, assistant professor of oncology at the University of Washington in Seattle. The studies discussed at the conference "bring us even closer to the goal of getting the best possible results with the fewest side effects," she added.

MRI VS MAMMOGRAPHY

One of the studies, presented by researchers in Germany, found that magnetic resonance imaging (MRI) is more accurate than mammography for detecting high-grade ductal carcinoma in situ (DCIS), the preinvasive form of breast cancer that is most likely to progress to an aggressive form.

A recently completed phase . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?